Costunolide derivative

Details

Top
Internal ID aba2bced-3985-4739-a47e-32ec422f2f23
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene lactones > Sesquiterpene lactones > Germacranolides and derivatives
IUPAC Name (3R,3aS,6E,9R,10E,11aS)-9-hydroxy-3,6,10-trimethyl-3a,4,5,8,9,11a-hexahydro-3H-cyclodeca[b]furan-2-one
SMILES (Canonical) CC1C2CCC(=CCC(C(=CC2OC1=O)C)O)C
SMILES (Isomeric) C[C@@H]1[C@@H]2CC/C(=C/C[C@H](/C(=C/[C@H]2OC1=O)/C)O)/C
InChI InChI=1S/C15H22O3/c1-9-4-6-12-11(3)15(17)18-14(12)8-10(2)13(16)7-5-9/h5,8,11-14,16H,4,6-7H2,1-3H3/b9-5+,10-8+/t11-,12+,13-,14-/m1/s1
InChI Key RLHPCSSGTQNSJN-QMPNBSENSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O3
Molecular Weight 250.33 g/mol
Exact Mass 250.15689456 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP 1.80
Atomic LogP (AlogP) 2.60
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
COSTUNOLIDE DERIV
NSC375091
NSC-375091

2D Structure

Top
2D Structure of Costunolide derivative

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9962 99.62%
Caco-2 + 0.8804 88.04%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability + 0.5857 58.57%
Subcellular localzation Mitochondria 0.5365 53.65%
OATP2B1 inhibitior - 0.8560 85.60%
OATP1B1 inhibitior + 0.9412 94.12%
OATP1B3 inhibitior + 0.9640 96.40%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior + 0.5500 55.00%
BSEP inhibitior - 0.9000 90.00%
P-glycoprotein inhibitior - 0.9244 92.44%
P-glycoprotein substrate - 0.8279 82.79%
CYP3A4 substrate + 0.5399 53.99%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8313 83.13%
CYP3A4 inhibition - 0.6936 69.36%
CYP2C9 inhibition - 0.9491 94.91%
CYP2C19 inhibition - 0.8917 89.17%
CYP2D6 inhibition - 0.9487 94.87%
CYP1A2 inhibition + 0.5573 55.73%
CYP2C8 inhibition - 0.9352 93.52%
CYP inhibitory promiscuity - 0.9563 95.63%
UGT catelyzed + 0.6362 63.62%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6067 60.67%
Eye corrosion - 0.9667 96.67%
Eye irritation - 0.9131 91.31%
Skin irritation + 0.5967 59.67%
Skin corrosion - 0.9370 93.70%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7342 73.42%
Micronuclear - 0.8800 88.00%
Hepatotoxicity + 0.7500 75.00%
skin sensitisation - 0.6178 61.78%
Respiratory toxicity + 0.5556 55.56%
Reproductive toxicity + 0.5667 56.67%
Mitochondrial toxicity + 0.6875 68.75%
Nephrotoxicity - 0.6123 61.23%
Acute Oral Toxicity (c) III 0.5030 50.30%
Estrogen receptor binding - 0.7009 70.09%
Androgen receptor binding - 0.6497 64.97%
Thyroid receptor binding - 0.5577 55.77%
Glucocorticoid receptor binding + 0.6682 66.82%
Aromatase binding - 0.8287 82.87%
PPAR gamma - 0.6934 69.34%
Honey bee toxicity - 0.8831 88.31%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity - 0.5800 58.00%
Fish aquatic toxicity + 0.9515 95.15%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.79% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 90.08% 91.11%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.87% 100.00%
CHEMBL1871 P10275 Androgen Receptor 85.60% 96.43%
CHEMBL2581 P07339 Cathepsin D 85.26% 98.95%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 84.66% 86.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 84.30% 89.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.02% 97.25%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 82.78% 93.03%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 82.39% 99.23%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.28% 97.09%

Cross-Links

Top
PubChem 54607887
NPASS NPC12529
LOTUS LTS0052008
wikiData Q105240080